Linda Mooberry, Ph.D.
Affiliations: | 2009 | Biochemistry and Molecular Biology | University of North Texas Health Science Center at Fort Worth |
Area:
Biochemistry, OncologyGoogle:
"Linda Mooberry"Parents
Sign in to add mentor| Andras G. Lacko | grad student | 2009 | University of North Texas Health Science Center at Fort Worth | |
| (Evaluation of reconstituted high density lipoprotein as an anticancer drug delivery platform.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen X, Mangala LS, Mooberry L, et al. (2019) Identifying and targeting angiogenesis-related microRNAs in ovarian cancer. Oncogene |
| Raut S, Mooberry L, Sabnis N, et al. (2018) Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy. Frontiers in Pharmacology. 9: 1154 |
| Raut S, Dasseux JL, Sabnis NA, et al. (2018) Lipoproteins for therapeutic delivery: recent advances and future opportunities. Therapeutic Delivery |
| Mooberry LK, Sabnis NA, Panchoo M, et al. (2016) Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging. Frontiers in Pharmacology. 7: 466 |
| McConathy WJ, Paranjape S, Mooberry L, et al. (2011) Validation of the reconstituted high-density lipoprotein (rHDL) drug delivery platform using dilauryl fluorescein (DLF). Drug Delivery and Translational Research. 1: 113-20 |
| Mooberry LK, Nair M, Paranjape S, et al. (2010) Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. Journal of Drug Targeting. 18: 53-8 |
| McConathy WJ, Nair MP, Paranjape S, et al. (2008) Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel. Anti-Cancer Drugs. 19: 183-8 |
| Lacko AG, Nair M, Paranjape S, et al. (2006) Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model. Chemotherapy. 52: 171-3 |